{"id":"F2008B00068","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 7 of 1996)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72280,"registerId":"commonwealth-F2008B00068-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 7 of 1996)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 7 of 1996\n\nI, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 May 1996.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAdrenaline\n\nDated this seventeenth day of April 1996.\n\nA. STEVENS\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Family Services\n\nDelegate of the Minister for Health and Family Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1562},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The declaration performs exactly the limited, specific function authorised by subsection 85(2AA) of the National Health Act 1953—removing a named drug from the pharmaceutical benefits list. There is no expansion beyond the original legislative purpose."},"complexity_factors":["Single substantive provision affecting one specific substance","No interpretation section or defined terms","No conditional logic, exceptions, or nested provisions","Minimal cross-referencing (only cites the empowering provision of the parent Act)"],"plain_english_summary":"This declaration removes Adrenaline from Australia’s Pharmaceutical Benefits Scheme as of 1 May 1996. Patients and prescribers will lose PBS subsidy for Adrenaline, so prescriptions must be paid at full commercial price rather than the PBS co‑payment.\n\nThe change was made by a Department of Health delegate, following advice from the Pharmaceutical Benefits Advisory Committee, as a routine update to the PBS schedule."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-7-of-1996/documents"}}